SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001345281-22-000001
Filing Date
2022-06-21
Accepted
2022-06-21 17:27:21
Documents
1
Period of Report
2022-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1485
  Complete submission text file 0001345281-22-000001.txt   3070
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2424 N FEDERAL HIGHWAY SUITE 208 BOCA RATON FL 33431
Business Address
DeSantis Damon (Reporting) CIK: 0001889279 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31668 | Film No.: 221029162